Stakeholder and patient feedback has pushed Pharmac into retaining a special program that provides funded access to medicines for children with cancer without an assessment by the controversial procurement agency.
Stakeholders force Pharmac backdown on move to scrap childhood cancer access program
March 19, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Ferronova secures funding to advance nanoparticle technology for cancer surgery
December 17, 2025 - - Australian Biotech -
Antimalarial candidate under WEHI-MSD partnership offers fresh hope against resistance
December 17, 2025 - - Latest News -
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Budget update repeats the 'fiscal illusion' that has become PBS spending
December 17, 2025 - - Latest News -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News

